My understanding is that the decision was made purely on the...

My understanding is that the decision was made purely on the primary/functional endpoint (PUL 2.0 score).

i.e. They have clinical data BUT (to my knowledge) are awaiting lab data / haven't seen any of that at all.

That is to say that they wouldn't have seen data pertaining to lymphocyte counts, fat fractions, etc yet.

Funnily enough, I flicked an email off asking to confirm that they haven't seen any lab data earlier this arvo. I'd asked previously (20Dec) without response. I generally avoid pestering, but it's important for me to know that the comm's to date have been through a purely functional lens.